EUVIMEDEUVIMED entdecken
Crossref

Bcl-2 knockdown by multifunctional lipid nanoparticle and its influence in apoptosis pathway regarding cutaneous melanoma: in vitro and ex vivo studies

Juliana Santos Rosa Viegas, Jackeline Souza Araujo, Marcel Nani Leite, Fabiola Garcia Praça, Jose Orestes Del Ciampo, Enilza Maria Espreáfico, Marco Andrey Cipriani Frade, Maria Vitória Lopes Badra Bentley iD

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-024-01692-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Juliana Santos Rosa Viegas und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Apoptosis, Proto-Oncogene Proteins c-bcl-2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multifunctional therapies have emerged as innovative strategies in cancer treatment. In this research article, we proposed a nanostructured lipid carrier (NLC) designed for the topical treatment of cutaneous melanoma, which simultaneously delivers 5-FU and Bcl-2 siRNA. The characterized nanoparticles exhibited a diameter of 259 ± 9 nm and a polydispersion index of 0.2, indicating a uniform size distribution. The NLCs were primarily localized in the epidermis, effectively minimizing the systemic release of 5-FU across skin layers. The ex vivo skin model revealed the formation of a protective lipid film, decreasing the desquamation process of the stratum corneum which can be associated to an effect of increasing permeation. In vitro assays demonstrated that A375 melanoma cells exhibited a higher sensitivity to the treatment compared to non-cancerous cells, reflecting the expected difference in their metabolic rates. The uptake of NLC by A375 cells reached approximately 90% within 4 h. The efficacy of Bcl-2 knockdown was thoroughly assessed using ELISA, Western blot, and qRT-PCR analyses, revealing a significant knockdown and synergistic action of the NLC formulation containing 5-FU and Bcl-2 siRNA (at low concentration --100 pM). Notably, the silencing of Bcl-2 mRNA also impacted other members of the Bcl-2 protein family, including Mcl-1, Bcl-xl, BAX, and BAK. The observed modulation of these proteins strongly indicated the activation of the apoptosis pathway, suggesting a successful inhibition of melanoma growth and prevention of its in vitro spread.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsApoptosisProto-Oncogene Proteins c-bcl-2NanoparticlesRNA, Small InterferingLipidsFluorouracilHumansCell Line, TumorGene Knockdown TechniquesCutaneous Malignant MelanomaDrug CarriersLiposomes

Stichwörter der Autor:innen

5-FluorouracilBcl-2 siRNALipid nanoparticleMelanomaTopical delivery

Substanzen

Proto-Oncogene Proteins c-bcl-2RNA, Small InterferingLipidsFluorouracilLipid NanoparticlesBCL2 protein, humanDrug CarriersLiposomes

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
  • Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
  • Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
  • Department of Cell and Molecular Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
  • School of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. vbentley@usp.br.

ORCID-Profile: Maria Vitória Lopes Badra Bentley

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Viegas, J. S. R., Araujo, J. S., Leite, M. N., Praça, F. G., Ciampo, J. O. D., Espreáfico, E. M., Frade, M. A. C., & Bentley, M. V. L. B. (2025). Bcl-2 knockdown by multifunctional lipid nanoparticle and its influence in apoptosis pathway regarding cutaneous melanoma: in vitro and ex vivo studies. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01692-w

Vancouver

Viegas JSR, Araujo JS, Leite MN, Praça FG, Ciampo JOD, Espreáfico EM, et al. Bcl-2 knockdown by multifunctional lipid nanoparticle and its influence in apoptosis pathway regarding cutaneous melanoma: in vitro and ex vivo studies. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01692-w

BibTeX
@article{Viegas2025,
  author = {Viegas, Juliana Santos Rosa and Araujo, Jackeline Souza and Leite, Marcel Nani and Praça, Fabiola Garcia and Ciampo, Jose Orestes Del and Espreáfico, Enilza Maria and Frade, Marco Andrey Cipriani and Bentley, Maria Vitória Lopes Badra},
  title = {Bcl-2 knockdown by multifunctional lipid nanoparticle and its influence in apoptosis pathway regarding cutaneous melanoma: in vitro and ex vivo studies},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-024-01692-w}
}
Kostenlos starten →